ClinicalTrials.Veeva

Menu

Performance and Safety Use of the Nanostructured Titanium Dental Implant "KONTACT N"

B

Biotech Dental

Status

Completed

Conditions

Edentulous Alveolar Ridge
Implant-supported Fixed Prosthesis
Dental Restoration
Dental Implant

Treatments

Device: dental implant (KONTACT N)

Study type

Observational

Funder types

Industry

Identifiers

NCT03582657
2018-A00194-51

Details and patient eligibility

About

A multicenter prospective observational study in which aim is to illustrate the clinical outcome of dental implants "Kontact N"; and the effects of its nanostructured surface on the osseointegration and secondary stability without increasing the rate of peri-implantitis. All the enrolled patients will be eligible for one or multiple implant-supported fixed restoration(s) according to the routine clinical practice and the manufacturer's instruction for use.

Enrollment

164 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Edentulous patient (partially or completely AND formerly, recently or just before implantation) requiring the placement of one (or more) dental implant (s) in maxillary or mandibular
  • Age ≥ 18 years
  • Good general health (ASA score between [1-2])
  • Sufficient bone volume and quality (with or without bone graft) to support the implant
  • Non-opposition of the patient for the collection of his medical data as part of the study (delivery of a patient's sheet)

Exclusion criteria

  1. Poor oral hygiene
  2. Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints
  3. Infections and oral inflammation such as periodontitis, gingivitis
  4. Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing
  5. Heavy smoker (> 10 cigarettes / day)
  6. Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy
  7. Patient on prolonged steroid therapy
  8. Titanium / titanium alloy allergy
  9. Alcohol or drug abuse
  10. Pregnant woman (or likely to be pregnant); or breastfeeding
  11. Difficulty of medical follow-up patients with geographical, social or psychological constraints
  12. Persons deprived of liberty or guardianship
  13. Involuntary / patient refusal to participate in the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems